Ataga KI, et al. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol [published online ahead of print February 21, 2022]. doi: 10.1038/s41581-022-00540-9; https://www.nature.com/articles/s41581-022-00540-9

• PubMed
Ataga KI, The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol [published online ahead of print February 21, 2022]. doi: 10.1038/s41581-022-00540-9; https://www.nature.com/articles/s41581-022-00540-9)| false
• Search Google Scholar
• Export Citation

Naik RP, Derebail VK. The spectrum of sickle hemoglobin-related nephropathy: From sickle cell disease to sickle trait. Expert Rev Hematol 2017; 10:1087–1094. doi: 10.1080/17474086.2017.1395279

• PubMed
Naik RP, Derebail VK. The spectrum of sickle hemoglobin-related nephropathy: From sickle cell disease to sickle trait. Expert Rev Hematol 2017; 10:1087–1094. doi: 10.1080/17474086.2017.1395279)| false
• Search Google Scholar
• Export Citation

Nath KA, Hebbel RP. Sickle cell disease: Renal manifestations and mechanisms. Nat Rev Nephrol 2015; 11:161–171. doi: 10.1038/nrneph.2015.8

• PubMed
Nath KA, Hebbel RP. Sickle cell disease: Renal manifestations and mechanisms. Nat Rev Nephrol 2015; 11:161–171. doi: 10.1038/nrneph.2015.8)| false
• Search Google Scholar
• Export Citation

Guasch A, et al. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 2006; 17:2228–2235. doi: 10.1681/ASN.2002010084

• PubMed
Guasch A, Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 2006; 17:2228–2235. doi: 10.1681/ASN.2002010084)| false
• Search Google Scholar
• Export Citation

Guasch A, et al. Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol 1999; 10:1014–1019. doi: 10.1681/ASN.V1051014

• PubMed
Guasch A, Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol 1999; 10:1014–1019. doi: 10.1681/ASN.V1051014)| false
• Search Google Scholar
• Export Citation

Ashley-Koch AE, et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 2011; 155:386–394. doi: 10.1111/j.1365-2141.2011.08832.x

• PubMed
Ashley-Koch AE, MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 2011; 155:386–394. doi: 10.1111/j.1365-2141.2011.08832.x)| false
• Search Google Scholar
• Export Citation

Quek L, et al. Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease. Br J Haematol 2010; 149:289–291. doi: 10.1111/j.1365-2141.2009.08062.x

• PubMed
Quek L, Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease. Br J Haematol 2010; 149:289–291. doi: 10.1111/j.1365-2141.2009.08062.x)| false
• Search Google Scholar
• Export Citation

Abbott KC, et al. Sickle cell nephropathy at end-stage renal disease in the United States: Patient characteristics and survival. Clin Nephrol 2002; 58:9–15. doi: 10.5414/cnp58009

• PubMed
Abbott KC, Sickle cell nephropathy at end-stage renal disease in the United States: Patient characteristics and survival. Clin Nephrol 2002; 58:9–15. doi: 10.5414/cnp58009)| false
• Search Google Scholar
• Export Citation

McClellan AC, et al. High one year mortality in adults with sickle cell disease and end-stage renal disease. Br J Haematol 2012; 159:360–367. doi: 10.1111/bjh.12024

• PubMed
McClellan AC, High one year mortality in adults with sickle cell disease and end-stage renal disease. Br J Haematol 2012; 159:360–367. doi: 10.1111/bjh.12024)| false
• Search Google Scholar
• Export Citation

Cecchini J, et al. Outcomes of adult patients with sickle cell disease admitted to the ICU: A case series*. Crit Care Med 2014; 42:1629–1639. doi: 10.1097/CCM.0000000000000316

• PubMed
Cecchini J, Outcomes of adult patients with sickle cell disease admitted to the ICU: A case series*. Crit Care Med 2014; 42:1629–1639. doi: 10.1097/CCM.0000000000000316)| false
• Search Google Scholar
• Export Citation

Yawn BP, et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA 2014; 312:1033–1048. doi: 10.1001/jama.2014.10517 [Erratums in JAMA 2014; 312:1932; JAMA 2015; 313:729].

• PubMed
Yawn BP, Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA 2014; 312:1033–1048. doi: 10.1001/jama.2014.10517 [Erratums in JAMA 2014; 312:1932; JAMA 2015; 313:729].)| false
• Search Google Scholar
• Export Citation

National Heart, Lung, and Blood Institute, National Institutes of Health. Evidence-based management of sickle cell disease. Expert panel report, 2014. 2014. https://www.nhlbi.nih.gov/sites/default/files/publications/56-364NFULL.pdf

• PubMed
National Heart, Lung, and Blood Institute, National Institutes of Health. Evidence-based management of sickle cell disease. Expert panel report, 2014. 2014. https://www.nhlbi.nih.gov/sites/default/files/publications/56-364NFULL.pdf)| false
• Search Google Scholar
• Export Citation

Sharpe CC, Thein SL. How I treat renal complications in sickle cell disease. Blood 2014; 123:3720–3726. doi: 10.1182/blood-2014-02-557439

• PubMed
Sharpe CC, Thein SL. How I treat renal complications in sickle cell disease. Blood 2014; 123:3720–3726. doi: 10.1182/blood-2014-02-557439)| false
• Search Google Scholar
• Export Citation

Ojo AO, et al. Renal transplantation in end-stage sickle cell nephropathy. Transplantation 1999; 67:291–295. doi: 10.1097/00007890-199901270-00018

• PubMed
Ojo AO, Renal transplantation in end-stage sickle cell nephropathy. Transplantation 1999; 67:291–295. doi: 10.1097/00007890-199901270-00018)| false
• Search Google Scholar
• Export Citation